Literature DB >> 15516960

The emerging roles of human tissue kallikreins in cancer.

Carla A Borgoño1, Eleftherios P Diamandis.   

Abstract

Human tissue kallikreins (hKs), which are encoded by the largest contiguous cluster of protease genes in the human genome, are secreted serine proteases with diverse expression patterns and physiological roles. Although primarily known for their clinical applicability as cancer biomarkers, recent evidence implicates hKs in many cancer-related processes, including cell-growth regulation, angiogenesis, invasion and metastasis. They have been shown to promote or inhibit neoplastic progression, acting individually and/or in cascades with other hKs and proteases, and might represent attractive targets for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15516960     DOI: 10.1038/nrc1474

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  181 in total

1.  Early induction of NRF2 antioxidant pathway by RHBDF2 mediates rapid cutaneous wound healing.

Authors:  Vishnu Hosur; Lisa M Burzenski; Timothy M Stearns; Michelle L Farley; John P Sundberg; Michael V Wiles; Leonard D Shultz
Journal:  Exp Mol Pathol       Date:  2017-03-06       Impact factor: 3.362

2.  Kallikrein 6 is a novel molecular trigger of reactive astrogliosis.

Authors:  Isobel A Scarisbrick; Maja Radulovic; Joshua E Burda; Nadya Larson; Sachiko I Blaber; Caterina Giannini; Michael Blaber; Alexander G Vandell
Journal:  Biol Chem       Date:  2012-04       Impact factor: 3.915

3.  Bauhinia bauhinioides cruzipain inhibitor reduces endothelial proliferation and induces an increase of the intracellular Ca2+ concentration.

Authors:  Mehmet Bilgin; Christiane Neuhof; Oliver Doerr; Utz Benscheid; Sheila S Andrade; Astrid Most; Yaser Abdallah; Mariana Parahuleva; Dursun Guenduez; Maria L Oliva; Ali Erdogan
Journal:  J Physiol Biochem       Date:  2010-08-02       Impact factor: 4.158

Review 4.  The regulatory crosstalk between kinases and proteases in cancer.

Authors:  Carlos López-Otín; Tony Hunter
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

Review 5.  Kallikreins - The melting pot of activity and function.

Authors:  Magdalena Kalinska; Ulf Meyer-Hoffert; Tomasz Kantyka; Jan Potempa
Journal:  Biochimie       Date:  2015-09-25       Impact factor: 4.079

6.  Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China.

Authors:  Min Shen; Roel Vermeulen; Preetha Rajaraman; Idan Menashe; Xingzhou He; Robert S Chapman; Meredith Yeager; Gilles Thomas; Laurie Burdett; Amy Hutchinson; Jeff Yuenger; Stephen Chanock; Qing Lan
Journal:  Environ Mol Mutagen       Date:  2009-05       Impact factor: 3.216

7.  Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma.

Authors:  Spyridon Christodoulou; Dimitra K Alexopoulou; Christos K Kontos; Andreas Scorilas; Iordanis N Papadopoulos
Journal:  Tumour Biol       Date:  2014-01-16

8.  Advanced high-grade serous ovarian cancer: inverse association of KLK13 and KLK14 mRNA levels in tumor tissue and patients' prognosis.

Authors:  Larissa Dettmar; Nancy Ahmed; Matthias Kotzsch; Sandra Diersch; Rudolf Napieralski; Dalila Darmoul; Manfred Schmitt; Wilko Weichert; Marion Kiechle; Julia Dorn; Viktor Magdolen
Journal:  J Cancer Res Clin Oncol       Date:  2018-03-15       Impact factor: 4.553

Review 9.  Pathogenesis of ovarian cancer: clues from selected overexpressed genes.

Authors:  Ie-Ming Shih; Ben Davidson
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

10.  PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancer.

Authors:  Alexandra Hockla; Erin Miller; Moh'd A Salameh; John A Copland; Derek C Radisky; Evette S Radisky
Journal:  Mol Cancer Res       Date:  2012-12       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.